Noopept (Omberacetam): 30mg

Description

Noopept (chemical name n-phenylacetyl-l-prolylglycine ethyl ester, also known as omberacetam or gvs-111) is a synthetic dipeptide developed in russia in 1996 as an orally bioavailable analogue of piracetam — approximately 1,000 times more potent per dose. it is one of the rare research peptides that works effectively via oral administration, crossing the blood-brain barrier within minutes. noopept is a prodrug metabolized in the body into its active form cycloprolylglycine, an endogenous dipeptide that acts as a positive modulator of ampa receptors and activates the bdnf/trkb signaling pathway. additional mechanisms include activation of the hypoxia-inducible factor 1 (hif-1) transcription pathway and upregulation of both bdnf and ngf expression. in russian clinical trials across 30+ years with over 1,000 subjects, noopept demonstrated 20-30% improvements on mmse cognitive scores versus placebo in patients with mild cognitive impairment. it also showed anxiolytic effects. standard protocol: 10mg twice daily for 1.5-3 month courses with at least 1 month break. oral administration — no reconstitution required. for research and educational purposes only.

Specifications

Dose Calculator